Vasiliy V Polosukhin Selected Research

Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)

11/2018	Lung Dendritic Cells Drive Natural Killer Cytotoxicity in Chronic Obstructive Pulmonary Disease via IL-15Rα.
1/2018	Bacterial-derived Neutrophilic Inflammation Drives Lung Remodeling in a Mouse Model of Chronic Obstructive Pulmonary Disease.
4/2016	Airway bacteria drive a progressive COPD-like phenotype in mice with polymeric immunoglobulin receptor deficiency.
8/2011	Bronchial secretory immunoglobulin a deficiency correlates with airway inflammation and progression of chronic obstructive pulmonary disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vasiliy V Polosukhin Research Topics

Disease

20	Inflammation (Inflammations) 01/2022 - 04/2006
13	Fibrosis (Cirrhosis) 01/2022 - 01/2005
12	Pneumonia (Pneumonitis) 04/2016 - 11/2005
9	Neoplasms (Cancer) 01/2022 - 03/2007
9	Chronic Obstructive Pulmonary Disease (COPD) 11/2021 - 08/2011
8	Carcinogenesis 01/2022 - 03/2007
6	Asthma (Bronchial Asthma) 01/2022 - 12/2009
5	Lung Injury 02/2016 - 04/2006
5	Hyperplasia 12/2011 - 12/2009
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 04/2005
4	Emphysema 01/2021 - 04/2016
4	Respiratory Hypersensitivity 10/2018 - 05/2009
4	Airway Remodeling 01/2018 - 05/2010
4	Hypoxia (Hypoxemia) 12/2015 - 05/2007
3	Lung Neoplasms (Lung Cancer) 12/2019 - 11/2007
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2008
2	Hypertrophy 12/2021 - 05/2010
2	Sarcoidosis (Schaumann Disease) 01/2016 - 09/2014
2	Infections 06/2012 - 05/2009
2	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2012 - 06/2011
2	Idiopathic Pulmonary Fibrosis 10/2010 - 04/2010
2	Lung Diseases (Lung Disease) 05/2010 - 05/2007
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2008 - 11/2007
2	Acute Lung Injury 10/2007 - 04/2006
1	Adenocarcinoma of Lung 01/2022
1	Radiation Fibrosis Syndrome (Radiation Fibrosis) 01/2022
1	Tertiary Lymphoid Structures 01/2021
1	Necrosis 01/2021
1	Lewis Lung Carcinoma 12/2019
1	Disease Progression 04/2016

Drug/Important Bio-Agent (IBA)

14	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 01/2005
11	Proteins (Proteins, Gene)FDA Link 12/2019 - 05/2007
10	CollagenIBA 12/2021 - 01/2005
7	CytokinesIBA 01/2021 - 05/2007
6	Secretory Immunoglobulin A (SIgA)IBA 01/2021 - 08/2011
6	NF-kappa B (NF-kB)IBA 12/2009 - 04/2006
5	Urethane (Ethyl Carbamate)IBA 12/2019 - 11/2007
4	Interleukin-13IBA 01/2022 - 05/2009
4	Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA 11/2018 - 08/2011
4	Surface-Active Agents (Surfactants)IBA 06/2011 - 11/2005
3	AllergensIBA 01/2021 - 12/2009
3	Doxycycline (Periostat)FDA LinkGeneric 01/2018 - 05/2007
3	LipopolysaccharidesIBA 02/2016 - 05/2013
3	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2012 - 06/2011
3	Protein CIBA 06/2011 - 11/2005
2	Interleukin-4 (Interleukin 4)IBA 01/2022 - 05/2010
2	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 10/2018
2	LigandsIBA 01/2022 - 01/2022
2	Interleukin-5 (Interleukin 5)IBA 01/2022 - 01/2021
2	IntegrinsIBA 01/2022 - 01/2020
2	CarcinogensIBA 01/2022 - 01/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 12/2015
2	Interleukin-33IBA 01/2022 - 01/2021
2	AntigensIBA 01/2021 - 08/2011
2	Interleukin-17 (Interleukin 17)IBA 10/2018 - 06/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 01/2016
2	AntibodiesIBA 01/2018 - 12/2015
2	MucinsIBA 12/2015 - 05/2009
2	Clodronic Acid (Clodronate)IBA 12/2014 - 12/2011
2	X-Box Binding Protein 1IBA 06/2012 - 06/2011
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 04/2012 - 06/2011
2	Messenger RNA (mRNA)IBA 06/2011 - 05/2010
2	Carbonic Anhydrase IXIBA 06/2011 - 10/2007
2	I-kappa B KinaseIBA 05/2007 - 04/2006
1	ifetrobanIBA 01/2022
1	ThromboxanesIBA 01/2022
1	AgarIBA 01/2022
1	AndrogensIBA 01/2022
1	Dehydroepiandrosterone (DHEA)IBA 01/2022
1	Arachidonic Acid (Vitamin F)IBA 01/2022
1	F2-Isoprostanes (F2 Isoprostanes)IBA 01/2022
1	ProstaglandinsIBA 01/2022
1	4,4',4''- (4- propyl- ((1)H)- pyrazole- 1,3,5- triyl) tris-phenolIBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	NAD (NADH)IBA 01/2021
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	CCR2 ReceptorsIBA 01/2020
1	Vitamin K FDA Link 12/2019
1	GSK 1363089IBA 12/2019
1	Warfarin (Coumadin)FDA LinkGeneric 12/2019
1	c-Mer Tyrosine KinaseIBA 12/2019
1	Interleukin-15 (Interleukin 15)IBA 11/2018
1	Interleukin-15 Receptors (Interleukin 15 Receptor)IBA 11/2018
1	SmokeIBA 11/2018
1	Hormones (Hormone)IBA 10/2018
1	Immunoglobulin E (IgE)IBA 10/2018
1	Testosterone (Sustanon)FDA Link 10/2018
1	salicylhydroxamic acid (SHAM)IBA 10/2018
1	Tyrosine Kinase InhibitorsIBA 06/2016
1	ErbB Receptors (EGF Receptor)IBA 06/2016
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 04/2016
1	RoflumilastIBA 04/2016
1	Leukocyte Elastase (Neutrophil Elastase)IBA 04/2016
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2016
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2016
1	Peroxidase (Myeloperoxidase)IBA 01/2016

Therapy/Procedure

3	Therapeutics 01/2022 - 06/2013